*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Molecular Screening of Ambler class C and extended-spectrum ß-lactamases in multi-drug resistant Pseudomonas aeruginosa and selected species of Enterobacteriaceae

Author: SHAYMAA H. AL-KUBAISY, RAWAA A. HUSSEIN, MUSHTAK T.S. AL-OUQAILI
Abstract: Background and objective: As a major clinical concern worldwide, the occurrence of extended spectrum ß-lactamases (ESBLs) has been increasingly reported in Pseudomonas aeruginosa. The goal of the study for the detection the occurrence of ß-lactamase bla-OXA specifically, the OXA II gene and III in study isolates and its role in the resistance pattern. Patients and Methods: One-hundred of clinical specimens were obtained from different clinical sites. Antibiotic susceptibility testing was performed for the study isolates of Pseudomonas aeruginosa according to the recommendations laid down by CLSI. ESBLs confirmatory test had been done by double-disc synergy test. Bacterial DNA extraction was achieved using automated DNA extraction unit, SaMag, Italy. RT-PCR was used for amplification of ß-lactamase (blaOXA) genes and detected using agarose gel electrophoresis. Results: Out of 100 clinical specimens, 75 (75%) were culture-positive. Of these, 35 (46.7%) isolates were diagnosed as P. aeruginosa, 23 (30.7%) E. coli isolates and 17 (22.6%) K. pneumonia. Based on the confirmatory test for the extended-spectrum ß-lactamase production, 40 (53.33%) isolates were considered to produce ESBLs, including 22 (55%) P. aeruginosa, 8 (20%) K. pneumoniae, and 10 (25%) E. coli isolates. RT-PCR was then used to detect the presence of the OXAII and III genes in the K. pneumoniae, E. coli, and P. aeruginosa clinical isolates. Five (14.28%) isolates of P. aeruginosa were producing OXAII while three (8.57 %) of them produced OXAIII. Two(8.69%) isolates from E. coli for OXAII and III gene and 2(11.76%) isolates from K. pneumonia were positive for the presence of OXAII while Five (29.4%) of them produced OXAIII. Conclusion: PCR is so helpful for the identification of specific ß-lactamase genes. Also, the study suggested that a significant presence of blaOXA-II and blaOXA-III genes among study isolates were detected and the highlighting for the need for suitable infection control strategies to effectively treat patients and prevent the further distribution of these resistant organisms.
Keyword: ESBL; carbapenemase; oxacillinase; multidrug resistance
DOI: https://doi.org/10.31838/ijpr/2020.12.03.506
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free